ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,845 | -20.7% | 24,522 | -5.0% | 0.02% | -19.0% |
| Q2 2022 | $576,000 | +6.3% | 25,816 | +106.0% | 0.02% | -40.0% |
| Q2 2021 | $542,000 | -28.9% | 12,531 | -32.9% | 0.04% | -7.9% |
| Q1 2021 | $762,000 | +12.2% | 18,670 | +24.4% | 0.04% | +31.0% |
| Q4 2020 | $679,000 | +9.7% | 15,010 | -14.2% | 0.03% | 0.0% |
| Q3 2020 | $619,000 | -23.4% | 17,496 | -18.3% | 0.03% | -29.3% |
| Q2 2020 | $808,000 | +38.6% | 21,406 | +6.1% | 0.04% | -2.4% |
| Q1 2020 | $583,000 | +64.7% | 20,175 | +195.1% | 0.04% | +162.5% |
| Q4 2019 | $354,000 | -48.3% | 6,836 | -45.2% | 0.02% | -54.3% |
| Q3 2019 | $685,000 | -17.7% | 12,482 | -39.1% | 0.04% | -23.9% |
| Q2 2019 | $832,000 | -6.5% | 20,492 | -30.4% | 0.05% | -14.8% |
| Q1 2019 | $890,000 | +16.0% | 29,423 | +22.7% | 0.05% | -10.0% |
| Q2 2018 | $767,000 | – | 23,972 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |